In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

Performance of oral anticoagulants in high risk patient populations with atrial fibrillation

EHRA webinar

08/02/2019 18:00 08/02/2019 19:00 Europe/Paris Performance of oral anticoagulants in high risk patient populations with atrial fibrillation

Access event page

European Heart Rhythm Association DD/MM/YYYY
Atrial Fibrillation
European Heart Rhythm Association
Cardiovascular Pharmacotherapy
Arrhythmias and Device Therapy

Focus on

New: measure your knowledge gain with the pre and post evaluation

Learning objectives

  • Is anticoagulation management for AF different in the frail and very elderly?
  • When and how to restart anticoagulant therapy after moderate to severe bleeding?
  • Does the HAS-BLED still have a role in anticoagulation management?

Watch the webinar recording




hohnloser_stefan h-2015.jpgProfessor Stefan Hohnloser
Klinikum der J.-W.-Goethe-Universitat


Collins-Ronan-2018Associate Professor Ronan Collins
Tallaght Hospital
Age-Related Health Care / Stroke-Service


steffel_jan-2015.jpgProfessor Jan Steffel, FESC
University Heart Center

Session information

This webinar addresses EHRA members and cardiologists working in the field of arrhythmias.

During the webinar, you will be encouraged to send your questions by chat and interact with our key opinion leaders who will provide live feedback.

Technical settings

The webinar is available on PC and tablets. The use of a smartphone is not recommended.

To answer the MCQs during the live, you must allow pop-up windows.

A high-speed Internet connection is required (minimum 2 Mbps).